Stocks and InvestingStocks and Investing
Fri, June 25, 2021
Thu, June 24, 2021
Wed, June 23, 2021
Tue, June 22, 2021
Mon, June 21, 2021
Sun, June 20, 2021
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021

Raghuram Selvaraju Maintained (ACRS) at Strong Buy with Increased Target to $50 on, Jun 16th, 2021


Published on 2024-10-27 16:59:52 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy with Increased Target from $40 to $50 on, Jun 16th, 2021.

Raghuram has made no other calls on ACRS in the last 4 months.



There are 2 other peers that have a rating on ACRS. Out of the 2 peers that are also analyzing ACRS, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Tuesday, June 15th, 2021
  • Thomas Smith of "SVB Leerink" Maintained at Buy with Increased Target to $26 on, Thursday, March 4th, 2021